©2021-2032 All Rights Reserved. Online Journal of Veterinary Research.  You may not store these pages in any form except for your own personal use. All other usage or distribution is illegal under international copyright treaties. Permission to use any of these pages in any other way besides the before mentioned must be gained in writing from the publisher. This article is exclusively copyrighted in its entirety to onlinejournals@gmail.com publications. This article may be copied once but may not be, reproduced or  re-transmitted without the express permission of the editors. Linking: To link to this page or any pages linking to this page you must link directly to this page only here rather than put up your own page.


Online Journal of Veterinary Research ©

Established 1996
ISSN 1443-2285


Volume 25 (3): 168-172, 2021

Pharmacokinetics of nifedipine in hyperlipidemic male Wistar rats.


Venkata Rajesham V1, Rama Narsimha Reddy A2, Rajyalakshmi G2, Anbu J1, Narsimha Reddy Y2


1Department of Pharmacology, Velís college of Pharmacy, Chennai, 2Department of Pharmacology, University College of Pharmaceutical Sciences, Kakatiya University, Warangal, India.




Rajesham V, Reddy RN, Rajyalakshmi G,Anbu J,Reddy NY, Pharmacokinetics of nifedipine in hyperlipidemic male Wistar rats, Onl J Vet Res., 25 (3): 168-172, 2021. We report effects of hyperlipidemia on pharmacokinetics of nifedipine in male adult Wistar rats. Cholesterol was fed daily for 30 days to induce hyperlipidemia confirmed by lipid profiles. Then, 20mg/kg nifedipine from Nicholus Piramils supplement was fed daily for 7 days to 6 normal controls and 6 hyperlipidemic rats. On the 1st and 8th day, blood was taken for plasma nifedipine determined by HPLC. Compared with normal rats, in those fed high fat diet, plasma cholesterol increased ~52, trigliceride 48~ and low density lipoprotein 57% (P < 0.0005) by 30 days confirming hyperlipidemia. Compared with controls, at day 1 of nifepidime treatment we found increased peak concentrations (Cmax) 30%, area under curve (AUC) 34-48%, half-life (t1/2) 21%, clearance (CL/f) 25 and volume distribution V/F 28%(P < 0.05) in rats fed high fat diet. By day 8, Cmax increased 24%, half-life 21% and AUC0-α 13% due to 12% reduced clearance of nifedipine. These findings suggest that hyperlipidemia may reduce clearance of nifedipine due to altered protein binding or inhibition of cytochrome P-450 by excessive cell membrane cholesterol.


KEY-WORDS: Nifedipine, hyperlipidemia, Pharmacokinetics, standard cholesterol diet.